ophthalmologic exams
Otherophthalmologic exams such as vision, intraocular pressure, axial length and optical coherence tomography
NCT Number: NCT03434145
To evaluate the effect of hemodialysis on various ophthalmologic parameters in patients with end-stage kidney disease (ESRD).
Looking for future studies?
Notify Me20 year–80 year
All sexes
Observational
Subjects: patients with ESRD undergoing hemodialysis at the Dialysis Center of Hanyang Guri Hospital
Ocular parameters: visual acuity, intraocular pressure, axial length, OCT Other systemic parameters: body weight, ultrafiltration volume, and systolic/diastolic blood pressure
All measurements were performed near the dialysis center. Measurements were performed on Monday (for patients who underwent dialysis sessions on Monday, Wednesday, and Friday) or Tuesday (for patients who underwent dialysis sessions on Tuesday, Thursday, and Saturday.
All parameters were measured before and after the hemodialysis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ophthalmologic exams such as vision, intraocular pressure, axial length and optical coherence tomography
Time frame: immediately (within 10 minutes) before and after hemodialysis
retinal & choroidal thickness on OCT
Time frame: immediately (within 10 minutes) before and after hemodialysis
vessel density on OCTA
Time frame: immediately (within 10 minutes) before and after hemodialysis
intraocular pressure, retinal thickness, anterior chamber angle
Looking for future studies?
Notify MeHanyang University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04392440
Chronic Disease, Chronic Kidney Diseases
Rochester, New York, United States
View Trial DetailsNCT07058909
Acute Kidney Injury, Acute Renal Failure
Norfolk, Virginia, United States
View Trial DetailsNCT04910867
Apolipoprotein L1, Chronic Disease
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06332469
Chronic Disease, Chronic Kidney Diseases
Norrköping, Sweden
View Trial Details